Skip to main content

Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022

REDWOOD CITY, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2022 financial results will be released after market close on Tuesday, November 8th, 2022. Starting at 5:00 p.m. Eastern Time on November 8, 2022, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. The press release with the third quarter 2022 financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call.

A replay of the webcast will be available on http://investors.coherus.com following the conclusion of the live conference call.

Conference Call Information
When: Tuesday, November 8th, 2022, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and personal PIN to access the live call: https://register.vevent.com/register/BI79684ca1b45c46df988c8f9aac6f09af

Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

Coherus Contact Information:
Marek Ciszewski, SVP Investor Relations
Coherus Biosciences, Inc.
IR@coherus.com



Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.90
+0.93 (0.41%)
AAPL  269.64
+0.83 (0.31%)
AMD  259.00
-0.67 (-0.26%)
BAC  52.98
-0.04 (-0.07%)
GOOG  270.27
+0.34 (0.13%)
META  754.00
+3.18 (0.42%)
MSFT  552.78
+21.26 (4.00%)
NVDA  193.62
+2.13 (1.11%)
ORCL  283.22
+1.82 (0.65%)
TSLA  453.31
+0.89 (0.20%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.